Nelson Jeffrey Edward — SEC Form 4 Insider Trading Activity
Summary
Updated Jul 16, 2026
Nelson Jeffrey Edward is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market sales: $158K.
Profile
Jeffrey Edward Nelson is the Chief Operating Officer of Milestone Pharmaceuticals Inc. (ticker: MIST) as disclosed in the most recent SEC filing dated January 28, 2026. Milestone is a biopharmaceutical company focused on developing etripamil for the treatment of paroxysmal supraventricular tachycardia (PSVT). The SEC filing identifies him in the COO role, but does not provide additional public background details beyond his executive position.
Role
Insider
Notability
40/100
Board memberships
Milestone Pharmaceuticals Inc.
Awards & honors
Serves as Chief Operating Officer of Milestone Pharmaceuticals Inc. as of the 2026-01-28 SEC filing
Oversees company operations in alignment with Milestone's focus on etripamil development for PSVT
Jeffrey Edward Nelson is the Chief Operating Officer of Milestone Pharmaceuticals Inc. (ticker: MIST) as disclosed in the most recent SEC filing dated January 28, 2026. Milestone is a biopharmaceutical company focused on developing etripamil for the treatment of paroxysmal supraventricular tachycardia (PSVT). The SEC filing identifies him in the COO role, but does not provide a…
Has Nelson Jeffrey Edward been buying or selling stock?
Recorded transactions: 0 open-market purchases () and 2 open-market sales ($158K) across all tracked filings.
Where can I see all of Nelson Jeffrey Edward's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
